2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Neoplasm Metastasis
1
Insulin Resistance
1
Hyperandrogenism
1
Glucose Intolerance
1
Endometrial Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma
1
Anovulation
1
Anastomotic Leak
1
Adenomatous Polyposis Coli
1
Interventions
Metformin
8
Progesterone
6
Spironolactone
4
drospirenone and ethinyl estradiol combination
3
Inositol
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
Sugars
2
Folic Acid
2
Flutamide
2
Estradiol
2
Cyproterone Acetate
2
Clomiphene
2
maltodextrin
1
licogliflozin
1
bicalutamide
1
Yoga
1
Waist-Hip Ratio
1
Waist Circumference
1
Ultrasonography
1
Topiramate
1
Time
1
Thioctic Acid
1
Sodium Salicylate
1
Sex Characteristics
1
Physical Examination
1
Phlebotomy
1
Phenotype
1
Ovidrel
1
Magnesium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperandrogenism
×
Inulin
×
Clear all
NCT03864068
2026-01-07
INSUPP-PCOS
Milton S. Hershey Medical Center
Phase 2
Completed
154 enrolled